Zeke Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Zeke Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,060	Closed	-$299K	–	519
2019 Q4	$299K	Hold	2,060	–	–	0.02%	462
2019 Q3	$275K	Sell	2,060 -103	-5%	-$13.3K	0.02%	467
2019 Q2	$247K	Hold	2,163	–	–	0.02%	505
2019 Q1	$268K	Hold	2,163	–	–	0.02%	492
2018 Q4	$218K	Hold	2,163	–	–	0.02%	501
2018 Q3	$276K	Sell	2,163 -10	-0.5%	-$1.19K	0.02%	531
2018 Q2	$235K	Sell	2,173 -15,551	-88%	-$1.69M	0.02%	495
2018 Q1	$1.88M	Buy	17,724 +4,030	+29%	+$468K	0.17%	105
2017 Q4	$1.6M	Sell	13,694 -456	-3%	-$51.6K	0.17%	109
2017 Q3	$1.61M	Buy	14,150 +5,572	+65%	+$643K	0.22%	78
2017 Q2	$1.07M	Buy	8,578 +1,150	+15%	+$136K	0.21%	66
2017 Q1	$881K	Buy	7,428 +4,570	+160%	+$518K	0.18%	69
2016 Q4	$286K	Buy	+2,858	New	+$306K	0.08%	143

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Zeke Capital Advisors's ZBH Position: Q1 2020 in Review

Zeke Capital Advisors sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 2,060 shares — an estimated $299K sold.

Zeke Capital Advisors first reported a position in ZBH in Q4 2016 and held it in 13 quarters. The position peaked at $1.88M in Q1 2018. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Zeke Capital Advisors reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Zeke Capital Advisors sold 2,060 Zimmer Biomet shares in Q1 2020, an estimated $299K.
Zeke Capital Advisors first reported a position in Zimmer Biomet in Q4 2016 and held it in 13 quarters.
Zeke Capital Advisors's Zimmer Biomet position peaked at $1.88M in Q1 2018.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Zeke Capital Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.